Back to 
M&T Bank Corp.
M&T Bank Corp.
SMMT
Showing 0 of 2 quarters
Position history for M&T Bank Corp.'s holdings in Summit Therapeutics Inc.
No. M&T Bank exited its SMMT (Summit Therapeutics) position in Q3 2020. Its Q2 2020 13F listed 25,000 shares worth $74,000. M&T Bank first reported SMMT in Q2 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.